The Patricia Hall Talbott Legacy Centers, LLC (Talbott Legacy Centers) is a Tennessee Limited Liability Company (LLC) that was formed in June of 2019 and named after the mother of TLC President, Zac Talbott, and TLC Executive Vice President, Leslie Tummel. 

Patricia Hall (Pat) Talbott was a native of Tellico Plains, Tennessee, who met her husband after being set up on a blind date while a student at the University of Tennessee in Knoxville. After their marriage, she moved to her husband's hometown of Maryville where they subsequently raised their children. She was a Physical Therapist with the Blount County School System, and she modeled public service and care for the "least of these" in both her personal and professional life. A woman of deep faith, she oversaw various initiatives to ensure that underprivileged and special needs children had food and gifts during the holidays, and she was even known to teach physically disabled children how to participate in various sporting events or use prosthetic limbs on her own time. After a battle with mesothelioma due to asbestos exposure, she passed away on December 14, 1996, leaving a legacy that will be remembered for generations.

The leadership of Talbott Legacy Centers (TLC) seeks to emulate their namesake's legacy of service to vulnerable, stigmatized populations through the provision of evidence-based, ethically-sound, and quality comprehensive treatment services for opioid and other substance use disorders. 

TLC's core values are rooted in EVIDENCE, INTEGRITY, ETHICS, DIVERSITY, and the DIGNITY of every person without regard to physical, mental, substance use, or other disorders. 

"...and what does the Lord require of you but to do justice, and to love kindness, and to walk humbly with your God?"  -Micah 6:8 (NRSV)

Acknowledging the collective evidence base that unequivocally demonstrates opioid use disorder is a chronic brain disorder that manifests through behavior, Talbott Legacy Centers (TLC) provides comprehensive treatment for opioid use disorder using FDA-approved agonist, partial agonist, or antagonist medications (i.e. methadone, buprenorphine, or naltrexone) along with individual and group counseling, ongoing medical evaluation, recovery support services, case management/care coordination, and other services within TLC’s facility and/or through referral to and collaborative agreement with outside agencies. 

TLC patients are individuals with opioid use disorder who are seeking treatment and attempting to change and/or improve their quality of life. TLC recognizes the complexity of working with this specialty population and therefore provides care in medical, psychological, sociological, economical, and spiritual areas of treatment. All treatment at TLC will be conducted in an environment that promotes positive encouragement and the dignity of all patients served.

TLC is committed to meeting the expectations of the staff, patients, and the community in which we operate. We accept objective evidence and, as such, acknowledge FDA-approved medications for opioid use disorder and substance use disorders are valid tools that improve treatment outcomes when utilized within a comprehensive treatment environment. Treatment should be available to provide support, education, counseling, and resources when individuals with opioid use disorder seek help.

As proven throughout the collective evidence base, FDA-approved medications for opioid use disorder, when utilized within a comprehensive treatment plan, provide a service to the community through the reduction of drug-related crime, medical treatment and emergency room visits, and public assistance utilization. TLC's evidence-based approach to care also reduces the spread of communicable diseases such as Hepatitis C and HIV/AIDS through lowering and eliminating injection opioid use.